| Call Number (LC) | Title | Results |
|---|---|---|
| RM301.25 .P43 2011 |
Pharmaceutical process development current chemical and engineering challenges / Pharmaceutical process development : current chemical and engineering challenges / |
2 |
| RM301.25 .P43 2012eb | Pediatric non-clinical drug testing : principles, requirements, and practice / | 1 |
| RM301.25 .P43 2020 | Pharmaceutical drug product development and process optimization : effective use of quality by design / | 1 |
| RM301.25 .P437 2020 | Pharmacological advances in natural product drug discovery | 1 |
| RM301.25 .P49 2011eb | Pharmaceutical process development current chemical and engineering challenges / | 1 |
| RM301.25 .P53 2001 | Pharmaceutical technology assessment for managed care : current practice and suggestions for improvement / | 1 |
| RM301.25 .P532 2016eb | Pharmaceutical product development : insights into pharmaceutical processes, management and regulatory affairs / | 1 |
| RM301.25 .P538 2017 | Platform technologies in drug discovery and validation / | 1 |
| RM301.25 .P64 2003eb | Polymer drugs in the clinical stage : advantages and prospects / | 1 |
| RM301.25 .P65 2011eb | Polyamine drug discovery | 1 |
| RM301.25 .P65 2012 | Polyamine drug discovery / | 1 |
| RM301.25 .P65 2012eb |
Polypharmacology in drug discovery / Polypharmacology in drug discovery |
2 |
| RM301.25 .P678 2015eb |
Post-genomic approaches in drug and vaccine development Post-genomic approaches in drug and vaccine development / |
2 |
| RM301.25 .P73 2022 | Practical application of supercritical fluid chromatography for pharmaceutical research and development / | 1 |
| RM301.25 .P745 2010eb | Preclinical drug development | 1 |
| RM301.25 .P75 2002eb | Principles and practice of pharmaceutical medicine / | 1 |
| RM301.25 .P757 2012eb |
Protein and peptide mass spectrometry in drug discovery / Protein and peptide mass spectrometry in drug discovery |
2 |
| RM301.25 .P76 2002 | Proteinase and peptidase inhibition : recent potential targets for drug development / | 1 |
| RM301.25 .P76 2002eb | Proteinase and peptidase inhibition : recent potential targets for drug development / | 1 |
| RM301.25 .Q35 2007eb | Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection. | 1 |
